Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion

被引:26
|
作者
Dolan, Michelle [3 ]
Cioc, Adina [3 ]
Cross, Nicholas C. P. [4 ,5 ]
Neglia, Joseph P. [1 ,2 ]
Tolar, Jakub [1 ,2 ]
机构
[1] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, 420 Delaware St SE,MMC 366, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Pediat, Div Hematol Oncol, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[4] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England
[5] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England
关键词
BCR; BCR-FGFR1 gene fusion; FGFR1; hematopoietic cell transplantation; 8p11 myeloproliferative syndrome; LYMPHOBLASTIC LYMPHOMA; INTERFERON-ALPHA; DISORDER; EOSINOPHILIA; PATIENT; FGFR1; TRANSLOCATIONS; MALIGNANCY; LEUKEMIA; T(8/22);
D O I
10.1002/pbc.23404
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report the case of a child who presented with nonspecific symptoms suggestive of a rheumatologic disorder, whose bone marrow had a complex translocation involving the FGFR1 locus. Hematopathologic findings were subtle and did not definitively indicate malignancy. Because he responded poorly to initial treatment with hydroxyurea, and in light of the progressive clinical course associated with the 8p11 myeloproliferative syndrome, he underwent an unrelated-donor hematopoietic stem cell transplant. This patient's atypical presentation highlights the importance of obtaining cytogenetic analysis at the time of bone marrow sampling and considering this uncommon entity in the differential diagnosis of hematologic disorders. Pediatr Blood Cancer 2012; 59: 194196. (C) 2011 Wiley Periodicals, Inc.
引用
收藏
页码:194 / 196
页数:3
相关论文
共 50 条
  • [31] The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1
    Walz, C
    Chase, A
    Schoch, C
    Weisser, A
    Schlegel, F
    Hochhaus, A
    Fuchs, R
    Schmitt-Gräff, A
    Hehlmann, R
    Cross, NCP
    Reiter, A
    LEUKEMIA, 2005, 19 (06) : 1005 - 1009
  • [32] Screening of Drugs to Treat 8p11 Myeloproliferative Syndrome Using Patient-Derived Induced Pluripotent Stem Cells with Fusion Gene CEP110-FGFR1
    Yamamoto, Shohei
    Otsu, Makoto
    Matsuzaka, Emiko
    Konishi, Chieko
    Takagi, Haruna
    Hanada, Sachiyo
    Mochizuki, Shinji
    Nakauchi, Hiromitsu
    Imai, Kohzoh
    Tsuji, Kohichiro
    Ebihara, Yasuhiro
    PLOS ONE, 2015, 10 (03):
  • [33] A novel t(1;8)(q25;p11.2) translocation associated with 8p11 myeloproliferative syndrome
    Yoshida, Chikamasa
    Takeuchi, Makoto
    Sadahira, Yoshito
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (02) : 271 - 273
  • [34] A case of a patient characterized by t(8;22)(p11;q11) and BCR/FGFR1 fusion gene, who was successfully treated with haploidentical hematopoietic stem cell transplantation
    Chen, Xin
    Huang, Lifang
    Zheng, Caifeng
    Wang, Zhiqiong
    HEMATOLOGY, 2021, 26 (01) : 691 - 696
  • [35] Ex Vivo Drug Sensitivity Evaluation of a ZMYM2::FGFR1 Fusion-Positive 8p11 Myeloproliferative Syndrome (EMS) Leukemia
    Beer, Sofia
    Leonard, Jessica T.
    Huang, Ariane
    Druker, Brian J.
    Tognon, Cristina
    BLOOD, 2023, 142
  • [36] 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript:: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality
    Park, Tae Sung
    Song, Jaewoo
    Kim, Jin Seok
    Yang, Woo Ick
    Song, Sungwook
    Kim, Sue Jung
    Suh, Borum
    Choi, Jong Rak
    CANCER GENETICS AND CYTOGENETICS, 2008, 181 (02) : 93 - 99
  • [37] Diagnostic application of next-generation sequencing in ZMYM2-FGFR1 8p11 myeloproliferative syndrome: A case report
    Wang, Yadan
    Wu, Xiaofei
    Deng, Jun
    Yu, Hao
    Xu, Ren
    Zhu, Zhiyi
    Tu, Shichun
    Hu, Yu
    CANCER BIOLOGY & THERAPY, 2016, 17 (08) : 785 - 789
  • [38] Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder:: The first fusion gene involving BCR but not ABL
    Fioretos, T
    Panagopoulos, I
    Lassen, C
    Swedin, A
    Billström, R
    Isaksson, M
    Strömbeck, B
    Olofsson, T
    Mitelman, F
    Johansson, B
    GENES CHROMOSOMES & CANCER, 2001, 32 (04): : 302 - 310
  • [39] Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma
    Costa, Luciano J.
    Kumar, Shaji
    Dispenzieri, Angela
    Hayman, Suzanne E.
    Buadi, Francis K.
    Dingli, David
    Litzow, Mark R.
    Gertz, Morie A.
    Lacy, Martha Q.
    LEUKEMIA & LYMPHOMA, 2009, 50 (05) : 781 - 787
  • [40] Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusion
    Mizuno, Shohei
    Takami, Akiyoshi
    Kawamura, Koji
    Harada, Kaito
    Masayoshi, Masuko
    Yano, Shingo
    Ito, Ayumu
    Ozawa, Yukiyasu
    Ouchi, Fumihiko
    Ashida, Takashi
    Nawa, Yuichiro
    Ichinohe, Tatsuo
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Yanada, Masamitsu
    EJHAEM, 2024, 5 (02): : 369 - 378